Work

Girard Sharp is investigating reports that Allstate, or its calling agent, sends prerecorded phone advertisements, or “robocalls,” to personal cell phones without the consent of the called parties.

Girard Sharp is investigating claims that Fiat Chrysler sold vehicles in violation of emissions regulations, prompting a mandatory recall in California.

On March 20, 2019, Girard Sharp filed a complaint against pharmaceutical companies AbbVie and Amgen alleging the companies engaged in anticompetitive practices with respect to the biologic drug Humira. Plaintiff Fraternal Order of Police Miami Lodge 20 Insurance Trust Fund, on behalf of itself and a proposed class of Humira purchasers, alleges that AbbVie has created a “thicket” of over 100 patents to frustrate other companies’ efforts to sell competing versions of Humira, and that AbbVie colluded with Amgen to keep Amgen’s product off the market, resulting in continued high prices for Humira.

Girard Sharp has filed a complaint following claims that Fidelity Investments is pocketing tens of millions of dollars per year at the expense of its retirement-plan clients by charging them hidden fees that may violate federal law.

$104.75 million settlement reached on the eve of trial on behalf of purchasers of the prescription drug Lidoderm.

$150 million partial settlement recovered for investors in various Jay Peak EB-5 Immigrant Investor Program project offerings, whose funds were diverted for unauthorized uses.